Sex differences in the vaccine-specific and non-targeted effects of vaccines

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Sex differences in the vaccine-specific and non-targeted effects of vaccines. / Flanagan, Katie L; Klein, Sabra L; Skakkebaek, Niels E; Marriott, Ian; Marchant, Arnaud; Selin, Liisa; Fish, Eleanor N; Prentice, Andrew M; Whittle, Hilton; Benn, Christine Stabell; Aaby, Peter.

In: Vaccine, Vol. 29, No. 13, 16.03.2011, p. 2349-54.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Flanagan, KL, Klein, SL, Skakkebaek, NE, Marriott, I, Marchant, A, Selin, L, Fish, EN, Prentice, AM, Whittle, H, Benn, CS & Aaby, P 2011, 'Sex differences in the vaccine-specific and non-targeted effects of vaccines', Vaccine, vol. 29, no. 13, pp. 2349-54. https://doi.org/10.1016/j.vaccine.2011.01.071

APA

Flanagan, K. L., Klein, S. L., Skakkebaek, N. E., Marriott, I., Marchant, A., Selin, L., Fish, E. N., Prentice, A. M., Whittle, H., Benn, C. S., & Aaby, P. (2011). Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine, 29(13), 2349-54. https://doi.org/10.1016/j.vaccine.2011.01.071

Vancouver

Flanagan KL, Klein SL, Skakkebaek NE, Marriott I, Marchant A, Selin L et al. Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine. 2011 Mar 16;29(13):2349-54. https://doi.org/10.1016/j.vaccine.2011.01.071

Author

Flanagan, Katie L ; Klein, Sabra L ; Skakkebaek, Niels E ; Marriott, Ian ; Marchant, Arnaud ; Selin, Liisa ; Fish, Eleanor N ; Prentice, Andrew M ; Whittle, Hilton ; Benn, Christine Stabell ; Aaby, Peter. / Sex differences in the vaccine-specific and non-targeted effects of vaccines. In: Vaccine. 2011 ; Vol. 29, No. 13. pp. 2349-54.

Bibtex

@article{5139bd6d1b444968900b06457b7d0211,

title = "Sex differences in the vaccine-specific and non-targeted effects of vaccines",

abstract = "Vaccines have non-specific effects (NSE) on subsequent morbidity and mortality from non-vaccine related infectious diseases. Thus NSE refers to any effect that cannot be accounted for by the induction of immunity against the vaccine-targeted disease. These effects are sex-differential, generally being more pronounced in females than males. Furthermore, the NSE are substantial causing greater than fifty percent changes in all cause mortality in certain settings, yet have never been systematically tested despite the fact that millions of children receive vaccines each year. As we strive to eliminate infectious diseases through vaccination programmes, the relative impact of NSE of vaccines on mortality is likely to increase, raising important questions regarding the future of certain vaccine schedules. A diverse group of scientists met in Copenhagen to discuss non-specific and sex-differential effects of vaccination, and explore plausible biological explanations. Herein we describe the contents of the meeting and the establishment of the 'Optimmunize' network aimed at raising awareness of this important issue among the wider scientific community.",

author = "Flanagan, {Katie L} and Klein, {Sabra L} and Skakkebaek, {Niels E} and Ian Marriott and Arnaud Marchant and Liisa Selin and Fish, {Eleanor N} and Prentice, {Andrew M} and Hilton Whittle and Benn, {Christine Stabell} and Peter Aaby",

year = "2011",

month = mar,

day = "16",

doi = "http://dx.doi.org/10.1016/j.vaccine.2011.01.071",

language = "English",

volume = "29",

pages = "2349--54",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

number = "13",

}

RIS

TY - JOUR

T1 - Sex differences in the vaccine-specific and non-targeted effects of vaccines

AU - Flanagan, Katie L

AU - Klein, Sabra L

AU - Skakkebaek, Niels E

AU - Marriott, Ian

AU - Marchant, Arnaud

AU - Selin, Liisa

AU - Fish, Eleanor N

AU - Prentice, Andrew M

AU - Whittle, Hilton

AU - Benn, Christine Stabell

AU - Aaby, Peter

PY - 2011/3/16

Y1 - 2011/3/16

N2 - Vaccines have non-specific effects (NSE) on subsequent morbidity and mortality from non-vaccine related infectious diseases. Thus NSE refers to any effect that cannot be accounted for by the induction of immunity against the vaccine-targeted disease. These effects are sex-differential, generally being more pronounced in females than males. Furthermore, the NSE are substantial causing greater than fifty percent changes in all cause mortality in certain settings, yet have never been systematically tested despite the fact that millions of children receive vaccines each year. As we strive to eliminate infectious diseases through vaccination programmes, the relative impact of NSE of vaccines on mortality is likely to increase, raising important questions regarding the future of certain vaccine schedules. A diverse group of scientists met in Copenhagen to discuss non-specific and sex-differential effects of vaccination, and explore plausible biological explanations. Herein we describe the contents of the meeting and the establishment of the 'Optimmunize' network aimed at raising awareness of this important issue among the wider scientific community.

AB - Vaccines have non-specific effects (NSE) on subsequent morbidity and mortality from non-vaccine related infectious diseases. Thus NSE refers to any effect that cannot be accounted for by the induction of immunity against the vaccine-targeted disease. These effects are sex-differential, generally being more pronounced in females than males. Furthermore, the NSE are substantial causing greater than fifty percent changes in all cause mortality in certain settings, yet have never been systematically tested despite the fact that millions of children receive vaccines each year. As we strive to eliminate infectious diseases through vaccination programmes, the relative impact of NSE of vaccines on mortality is likely to increase, raising important questions regarding the future of certain vaccine schedules. A diverse group of scientists met in Copenhagen to discuss non-specific and sex-differential effects of vaccination, and explore plausible biological explanations. Herein we describe the contents of the meeting and the establishment of the 'Optimmunize' network aimed at raising awareness of this important issue among the wider scientific community.

U2 - http://dx.doi.org/10.1016/j.vaccine.2011.01.071

DO - http://dx.doi.org/10.1016/j.vaccine.2011.01.071

M3 - Journal article

VL - 29

SP - 2349

EP - 2354

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 13

ER -

ID: 40219769

Forskning